Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Goldman Sachs
- TD Cowen
- Truist Securities
- Evercore ISI Group
- RBC Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Agilon Health
What is the target price for Agilon Health (AGL)?
The latest price target for Agilon Health (NYSE: AGL) was reported by Goldman Sachs on August 15, 2023. The analyst firm set a price target for $25.00 expecting AGL to rise to within 12 months (a possible 39.43% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Agilon Health (AGL)?
The latest analyst rating for Agilon Health (NYSE: AGL) was provided by Goldman Sachs, and Agilon Health maintained their buy rating.
When is the next analyst rating going to be posted or updated for Agilon Health (AGL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating Agilon Health (AGL) correct?
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $29.00 to $25.00. The current price Agilon Health (AGL) is trading at is $17.93, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.